Showing results (11-20 of 37) with videos related to
Sort By:
Pageof 4
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1989
Crystal versus solution structure of enzymes: NMR spectroscopy of a peptide boronic acid-serine protease complex in the crystalline stateS Farr-Jones, S O Smith, C A Kettner, et al.The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 28, 2002
Human autologous in vitro models of glioma immunogene therapy using B7-2, GM-CSF, and IL12Ian F Parney, Maxine A Farr-Jones, Kevin Kane, et al.Journal of Biomolecular Screening|September 16, 2006
High-throughput screening: update on practices and successSandra Fox, Shauna Farr-Jones, Lynne Sopchak, et al.Plos One|May 11, 2018
An ambient temperature-stable antitoxin of nine co-formulated antibodies for botulism caused by serotypes A, B and EMingxiang Li, Dennis Lee, Chidi R Obi, et al.Human Gene Therapy|June 10, 1997
Granulocyte-macrophage colony-stimulating factor and B7-2 combination immunogene therapy in an allogeneic Hu-PBL-SCID/beige mouse-human glioblastoma multiforme modelI F Parney, K C Petruk, C Zhang, et al.Journal of Neuro-Oncology|May 24, 2006
Technical hurdles in a pilot clinical trial of combined B7-2 and GM-CSF immunogene therapy for glioblastomas and melanomasIan F Parney, Lung-Ji Chang, Maxine A Farr-Jones, et al.Cancer Research|May 1, 1991
Development of a large-animal human brain tumor xenograft model in immunosuppressed catsB W Krushelnycky, M A Farr-Jones, B Mielke, et al.Toxins|May 26, 2026
Co-Expression and Co-Purification Enable Manufacturing of a Six-Monoclonal Antibody Botulinum Antitoxin CocktailAndrew Davis, Kamaljit Bajwa, Zachary Martinez, et al.Toxins|June 25, 2025
Single Tri-Epitopic Antibodies (TeAbs) to Botulinum Neurotoxin Serotypes B, E, and F Recapitulate the Full Potency of a Combination of Three Monoclonal Antibodies in Toxin NeutralizationJianlong Lou, Wei Hua Wen, Fraser Conrad, et al.Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|November 5, 2003
X-linked inhibitor regulating TRAIL-induced apoptosis in chemoresistant human primary glioblastoma cellsWilson H Roa, Hua Chen, Dorcas Fulton, et al.Pageof 4